Jazz Pharmaceuticals plc 4

Non-employee director Heather Ann McSharry received an equity award of 1,605 RSUs of Jazz Pharmaceuticals plc, bringing her direct holdings to 20,054 ordinary shares.

On August 5, 2026, Heather Ann McSharry, a non-employee director of Jazz Pharmaceuticals plc, received a grant of 1,605 restricted stock units (RSUs) representing ordinary shares under the company’s 2007 Amended and Restated Non-Employee Directors Stock Award Plan, increasing her direct beneficial ownership to 20,054 ordinary shares. Each RSU converts into one ordinary share upon vesting, which is scheduled to occur in full on July 23, 2027, contingent on continued service and certain additional conditions. No purchase or sale for cash occurred, and the RSUs were awarded at a stated price of $0.00 per unit as part of her director compensation.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

fda

Accession

0001576068-26-000004

Alert Tier

5